Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays.
暂无分享,去创建一个
Kevin R Coombes | Jing Wang | Lynne V Abruzzo | Lynn L Barron | Michael J Keating | Mini Kapoor | K. Coombes | M. Kapoor | Jing Wang | L. Medeiros | L. Abruzzo | M. Keating | Candy C Cromwell | L Jeffrey Medeiros | W Edward Highsmith | Lynn L. Barron | W. Edward Highsmith | Candy C. Cromwell | Kevin R. Coombes | W. Highsmith | Michael J. Keating | L. Medeiros
[1] Stan Pounds,et al. Estimating the Occurrence of False Positives and False Negatives in Microarray Studies by Approximating and Partitioning the Empirical Distribution of P-values , 2003, Bioinform..
[2] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[3] Steven L. Allen,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[4] Mallika Singh,et al. BSAP (Pax5)-Importin α1 (Rch1) Interaction Identifies a Nuclear Localization Sequence* , 2000, The Journal of Biological Chemistry.
[5] L. P. Gustavson,et al. Observations on the level of cyclic nucleotides in three population of human lymphocytes in culture. , 1980, Journal of cyclic nucleotide research.
[6] David M. Rocke,et al. Transformation and normalization of oligonucleotide microarray data , 2003, Bioinform..
[7] Arthur Weiss,et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.
[8] H. Döhner,et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. , 2002, Blood.
[9] D. Oscier,et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.
[10] Cheng Li,et al. DNA-Chip Analyzer (dChip) , 2003 .
[11] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] Adrian Wiestner,et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.
[14] C. Stewart,et al. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2003, American journal of clinical pathology.
[15] J. Zhang,et al. Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. , 2001, Biochemical and biophysical research communications.
[16] R. Zaru,et al. Cutting Edge: TCR Engagement and Triggering in the Absence of Large-Scale Molecular Segregation at the T Cell-APC Contact Site1 , 2002, The Journal of Immunology.
[17] Kevin R Coombes,et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. , 2003, Blood.
[18] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[19] Kevin R. Coombes,et al. Identifying Differentially Expressed Genes in cDNA Microarray Experiments , 2001, J. Comput. Biol..
[20] R. Tibshirani,et al. Empirical bayes methods and false discovery rates for microarrays , 2002, Genetic epidemiology.
[21] Douglas M. Hawkins,et al. A variance-stabilizing transformation for gene-expression microarray data , 2002, ISMB.
[22] R. Pagani,et al. Synthesis of adenine and guanine nucleotides at the 'inosinic branch point' in lymphocytes of leukemia patients. , 1999, Biochimica et biophysica acta.
[23] R. Salgia,et al. Involvement of p130Cas and p105HEF1, a Novel Cas-like Docking Protein, in a Cytoskeleton-dependent Signaling Pathway Initiated by Ligation of Integrin or Antigen Receptor on Human B Cells* , 1997, The Journal of Biological Chemistry.
[24] Christina A. Cuomo,et al. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] Cheng Li,et al. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.
[26] K. Coombes,et al. A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays , 2004, BMC Genomics.
[27] David M. Rocke,et al. A Model for Measurement Error for Gene Expression Arrays , 2001, J. Comput. Biol..